Psychological Effects of Lockdown Measures for the COVID-19 Outbreak in Patients with Systemic Lupus Erythematosus.
COVID-19
psychological distress
systemic lupus erythematosus
Journal
Journal of multidisciplinary healthcare
ISSN: 1178-2390
Titre abrégé: J Multidiscip Healthc
Pays: New Zealand
ID NLM: 101512691
Informations de publication
Date de publication:
2021
2021
Historique:
received:
18
03
2021
accepted:
05
05
2021
entrez:
25
6
2021
pubmed:
26
6
2021
medline:
26
6
2021
Statut:
epublish
Résumé
To compare the psychological impact of the lockdown measures contrasting the COVID-19 outbreak between systemic lupus erythematosus (SLE) and general population. From July 15th to August 15th 2020, a retrospective survey referring to the period March 9th to May 18th 2020 was administered to SLE patients and the results of the survey, called LEPRE (Lupus Erythematosus PREsto) study, were compared with those from the PRESTO (imPact of quaRantine mEasures againST cOvid19) project, the same survey provided to the general population. Consecutive patients >18 years old affected by SLE and regularly followed in a single rheumatologic centre were involved. Primary outcome was to compare the scores of the Impact of Events Scale-Revised (IES-R), the General Health Questionnaire 12 (GHQ-12) and the Center for Epidemiological Depression Scale (CES-D) between patients and general population. A total of 64 patients completed the survey. After a propensity score matching, they were compared to 128 people from PRESTO project. The median age among patients was 43 years (I-III interquartile range 35-54.5), 88% were female and 100% Caucasian. IES-R [(score>23: 57% (34) vs 49% (58)], GHQ-12 [(score>13: 85% (52) vs 88% (106)], and CES-D [(score>15: 45% (28) vs 40% (46)] scores were not statistically different between patients and controls (p>0.05). Restrictive measures for COVID-19 pandemic had no greater impact on patients with SLE than in the general population. Strategy for coping to the SLE might be useful during lockdown measures and may be helpful for other chronic conditions.
Identifiants
pubmed: 34168460
doi: 10.2147/JMDH.S311325
pii: 311325
pmc: PMC8216740
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1475-1488Informations de copyright
© 2021 Quartuccio et al.
Déclaration de conflit d'intérêts
No authors have any financial support or other benefits from commercial sources for the work reported on in the manuscript, or any other financial interests which could create a potential conflict of interest or the appearance of a conflict of interest concerning the work. The authors reported no conflicts of interest for this work.
Références
Rheumatology (Oxford). 2020 Dec 12;:
pubmed: 33313870
Ann Transl Med. 2019 Jan;7(1):16
pubmed: 30788363
Med Clin (Engl Ed). 2021 Apr 23;156(8):379-385
pubmed: 33754127
JAMA Psychiatry. 2020 Nov 1;77(11):1147-1154
pubmed: 32520326
Rheumatology (Oxford). 2020 Dec 5;59(Suppl5):v19-v28
pubmed: 33280016
Lupus. 2018 Dec;27(14):2284-2291
pubmed: 30451638
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Open Rheumatol J. 2014 Feb 21;8:1-8
pubmed: 24665352
J Rheumatol. 2020 Nov 15;:
pubmed: 33191284
Psychol Med. 1997 Jan;27(1):191-7
pubmed: 9122299
J Clin Med. 2020 Sep 05;9(9):
pubmed: 32899470
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
Open Access Rheumatol. 2020 Sep 22;12:215-222
pubmed: 33061689
Lancet. 2020 Mar 14;395(10227):912-920
pubmed: 32112714
Isr Med Assoc J. 2016 Mar-Apr;18(3-4):144-5
pubmed: 27228629